Related Experiment Videos
Vancomycin-resistant Staphylococcus aureus: an emerging public health threat
1Department of Hospital Pharmacy, Cleveland Clinic Foundation, OH 44195, USA.
Abstract:
Three reported cases of infection with strains of Staphylococcus aureus that had only intermediate susceptibility to vancomycin raise fears that high-level vancomycin resistance may soon be seen. To forestall this occurrence, physicians need to limit their use of vancomycin, and hospitals need to intensify their infection-control efforts. We review treatment options and the recommendations from the Centers for Disease Control and Prevention to identify and slow the spread of resistant strains.
Insights
Fears of high-level vancomycin resistance in Staphylococcus aureus are rising. Limiting vancomycin use and enhancing hospital infection control are crucial to prevent the spread of resistant strains.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Vancomycin is a critical antibiotic for treating Staphylococcus aureus infections.
- Emerging resistance threatens the efficacy of vancomycin.
Observation:
- Three cases of Staphylococcus aureus with intermediate vancomycin susceptibility have been reported.
- This suggests a potential progression towards high-level resistance.
Findings:
- The study highlights the urgent need to monitor and manage vancomycin susceptibility.
- Physicians must judiciously use vancomycin to preserve its effectiveness.
Implications:
- Hospitals must strengthen infection control measures to prevent the dissemination of resistant strains.
- Proactive strategies are essential to combat the growing threat of antimicrobial resistance.